| Mohamad Altayeb Al-hafez, MD | |
|
1221 Highland Ave, Clarkston, WA 99403-2829 | |
| (360) 754-5858 | |
| Not Available |
| Full Name | Mohamad Altayeb Al-hafez |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1221 Highland Ave, Clarkston, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265444723 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mohamad Altayeb Al-hafez, MD 560 Haight St., Unit 101, San Francisco, CA 94117 Ph: (415) 845-6040 | Mohamad Altayeb Al-hafez, MD 1221 Highland Ave, Clarkston, WA 99403-2829 Ph: (360) 754-5858 |
News Archive
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a randomized, four-way crossover alcohol-interaction study in healthy male and female moderate drinkers with Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
After studying the sleep characteristics of nearly 11,000 adults in an overnight sleep laboratory, Mayo Clinic researchers suggest that obstructive sleep apnea (OSA) - and, in particular, the low nighttime oxygen saturation of the blood it causes - may be a risk factor for sudden cardiac death (SCD).
Inspire Pharmaceuticals, Inc. announced today that Inspire scientists and collaborators will present data on denufosol tetrasodium, an investigational therapy for cystic fibrosis, during an oral presentation at the American Thoracic Society 2010 International Conference May 14 - 19, 2010 in New Orleans, LA.
The Johns Hopkins Brain Sciences Institute has funded a total of $5 million to 12 different research groups at Hopkins to launch the new Synapses, Circuits and Cognitive Disorders Program. The new BSi program aims to understand the fundamentals of brain function by focusing on the synapse — the point of contact between two nerve cells — to better understand cognitive disorders.
Cytori Therapeutics, Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application that protects key therapeutic methods for its breast and soft tissue reconstruction products. This patent will protect Cytori's existing and future products when sold in the U.S.
› Verified 1 days ago
Michael Minick, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1221 Highland Ave, Clarkston, WA 99403 Phone: 509-758-5511 | |
Mr. Jose Y Garcia Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1119 Highland Ave, Suite 5, Clarkston, WA 99403 Phone: 509-751-0312 Fax: 509-751-0314 | |
Nolan Derr, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1119 Highland Ave, Clarkston, WA 99403 Phone: 509-254-2722 | |
Murray I Larsen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 6th St, Clarkston, WA 99403 Phone: 509-758-2200 Fax: 509-758-6511 | |
Thomas Strobel, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1221 Highland Ave, Clarkston, WA 99403 Phone: 208-799-5522 | |
Daniel Ryan, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1119 Highland Ave, Clarkston, WA 99403 Phone: 509-758-4450 | |
Zeeshan Afzal, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1119 Highland Ave Ste 3, Clarkston, WA 99403 Phone: 509-780-4444 Fax: 509-780-4443 |